These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 9425066)

  • 1. Differences in binding modes of enantiomers of 1-acetamido boronic acid based protease inhibitors: crystal structures of gamma-chymotrypsin and subtilisin Carlsberg complexes.
    Stoll VS; Eger BT; Hynes RC; Martichonok V; Jones JB; Pai EF
    Biochemistry; 1998 Jan; 37(2):451-62. PubMed ID: 9425066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural comparison of two serine proteinase-protein inhibitor complexes: eglin-c-subtilisin Carlsberg and CI-2-subtilisin Novo.
    McPhalen CA; James MN
    Biochemistry; 1988 Aug; 27(17):6582-98. PubMed ID: 3064813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding, proteolytic, and crystallographic analyses of mutations at the protease-inhibitor interface of the subtilisin BPN'/chymotrypsin inhibitor 2 complex.
    Radisky ES; Kwan G; Karen Lu CJ; Koshland DE
    Biochemistry; 2004 Nov; 43(43):13648-56. PubMed ID: 15504027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
    Krystek S; Stouch T; Novotny J
    J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicted three-dimensional structural models of venom serine protease inhibitors and their interactions with trypsin and chymotrypsin.
    Azim MK; Grossmann JG; Zaidi ZH
    J Nat Toxins; 1999 Oct; 8(3):363-84. PubMed ID: 10591040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 13C NMR study of how the oxyanion pKa values of subtilisin and chymotrypsin tetrahedral adducts are affected by different amino acid residues binding in enzyme subsites S1-S4.
    O'Sullivan DB; O'Connell TP; Mahon MM; Koenig A; Milne JJ; Fitzpatrick TB; Malthouse JP
    Biochemistry; 1999 May; 38(19):6187-94. PubMed ID: 10320347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
    Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
    Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11B NMR spectroscopy of peptide boronic acid inhibitor complexes of alpha-lytic protease. Direct evidence for tetrahedral boron in both boron-histidine and boron-serine adduct complexes.
    Tsilikounas E; Kettner CA; Bachovchin WW
    Biochemistry; 1993 Nov; 32(47):12651-5. PubMed ID: 8251483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected tricovalent binding mode of boronic acids within the active site of a penicillin-binding protein.
    Zervosen A; Herman R; Kerff F; Herman A; Bouillez A; Prati F; Pratt RF; Frère JM; Joris B; Luxen A; Charlier P; Sauvage E
    J Am Chem Soc; 2011 Jul; 133(28):10839-48. PubMed ID: 21574608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The mobility of the side chains of His57 and other amino acid residues in the active center of chymotrypsin].
    Kostetskiĭ PV
    Biofizika; 2004; 49(4):595-600. PubMed ID: 15458241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting proteinase specificities from free energy calculations.
    Mekonnen SM; Olufsen M; Smalås AO; Brandsdal BO
    J Mol Graph Model; 2006 Oct; 25(2):176-85. PubMed ID: 16386933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refined crystal structure of the complex of subtilisin BPN' and Streptomyces subtilisin inhibitor at 1.8 A resolution.
    Takeuchi Y; Satow Y; Nakamura KT; Mitsui Y
    J Mol Biol; 1991 Sep; 221(1):309-25. PubMed ID: 1920411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A low-barrier hydrogen bond in subtilisin: 1H and 15N NMR studies with peptidyl trifluoromethyl ketones.
    Halkides CJ; Wu YQ; Murray CJ
    Biochemistry; 1996 Dec; 35(49):15941-8. PubMed ID: 8961961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of peptide bonds to inhibitor-protease binding: crystal structures of the turkey ovomucoid third domain backbone variants OMTKY3-Pro18I and OMTKY3-psi[COO]-Leu18I in complex with Streptomyces griseus proteinase B (SGPB) and the structure of the free inhibitor, OMTKY-3-psi[CH2NH2+]-Asp19I.
    Bateman KS; Huang K; Anderson S; Lu W; Qasim MA; Laskowski M; James MN
    J Mol Biol; 2001 Jan; 305(4):839-49. PubMed ID: 11162096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMBER force field implementation of the boronate function to simulate the inhibition of beta-lactamases by alkyl and aryl boronic acids.
    Tafi A; Agamennone M; Tortorella P; Alcaro S; Gallina C; Botta M
    Eur J Med Chem; 2005 Nov; 40(11):1134-42. PubMed ID: 16153747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enantiocomplementary enzymatic resolution of the chiral auxiliary: cis,cis-6-(2,2-dimethylpropanamido)spiro[4.4]nonan-1-ol and the molecular basis for the high enantioselectivity of subtilisin Carlsberg.
    Mugford PF; Lait SM; Keay BA; Kazlauskas RJ
    Chembiochem; 2004 Jul; 5(7):980-7. PubMed ID: 15239056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary structure and reactive site of a novel wheat proteinase inhibitor of subtilisin and chymotrypsin.
    Poerio E; Di Gennaro S; Di Maro A; Farisei F; Ferranti P; Parente A
    Biol Chem; 2003 Feb; 384(2):295-304. PubMed ID: 12675523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new substrate and two inhibitors applicable for thermitase, subtilisin BPN' and alpha-chymotrypsin. Comparison of kinetic parameters with customary substrates and inhibitors.
    Brömme D; Fittkau S
    Biomed Biochim Acta; 1985; 44(7-8):1089-94. PubMed ID: 3910035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of tetrahedral intermediate formation in the catalytic mechanism of the serine proteases chymotrypsin and subtilisin.
    Petrillo T; O'Donohoe CA; Howe N; Malthouse JP
    Biochemistry; 2012 Aug; 51(31):6164-70. PubMed ID: 22757750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.